Endometrial Receptivity Analysis (ERA): data versus opinions.

Area of Science:

• Reproductive Medicine
• Genomics
• Artificial Intelligence

Background:

• Precision medicine is revolutionizing healthcare through personalized diagnostics and treatments.
• Endometrial transcriptomics has identified the window of implantation (WOI), a critical period for embryo receptivity.
• Disruption of embryo-endometrial synchrony occurs in about 30% of in vitro fertilization (IVF) cycles, impacting success rates.

Purpose of the Study:

• To summarize and contextualize data on the endometrial receptivity analysis (ERA) test.
• To address criticisms and debates surrounding the clinical utility of the ERA test.
• To highlight the role of endometrial transcriptomics in achieving personalized embryo transfer (pET).

Main Methods:

• The ERA test utilizes next-generation sequencing (NGS) to analyze endometrial transcriptomic signatures.
• A computational predictor identifies specific transcriptomic profiles corresponding to proliferative, pre-receptive, receptive, and post-receptive endometrial stages.
• Data analysis is employed to validate the ERA test and its application in clinical practice.

Main Results:

• The ERA test accurately identifies transcriptomic signatures for different endometrial stages.
• It enables the determination of an individual's unique window of implantation (WOI).
• This facilitates personalized embryo transfer (pET) by synchronizing embryo implantation with the WOI.

Conclusions:

• The ERA test offers an objective method to assess endometrial receptivity.
• It has the potential to improve IVF outcomes by enabling personalized embryo transfer.
• Further data and reader interpretation are crucial for establishing the definitive clinical utility of the ERA test.